Acumen Pharmaceuticals, Inc. ($ABOS)
Filing Information
| Accession Number | 0001628280-26-014365 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
28,218
Total Value
$45,712.22
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer & Corp Sec | Common Stock | โ | Feb 27, 2026 | Exercise/Conversion | 9,406 | $1.85 | $17,401.10 | 183,405 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Common Stock | โ | Feb 27, 2026 | Sale | 9,406 | $3.01 | $28,311.12 | 173,999 | Direct | โ | View Details | |
Chief Legal Officer & Corp Sec | Employee Stock Option (right to buy) | Derivative | Feb 27, 2026 | Exercise/Conversion | 9,406 | $0.00 | $0.00 | 73,138 | Direct | โ | View Details |